Amarin Corp Plc (AMRN)

[couldbebetter]

BRAVE is a "proof of concept" study. If positive, maybe a retrospective study
could be done to determine if Vascepa has helped patients avoid Alzheimer's.
If an actual new trial is needed maybe a new formulation will be used, if such
could have its patent protected. Of course, none of this work out unless it is
done by a BP. Hopefully, that is the strategy that Alex Denner has in mind.